Pancreatic Cancer Research

ResearcherEmory UniversityActive in the last 2 years

Edmund K Waller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0816-6729; OpenAlex author ID A5011386306; NIH RePORTER profile ID 1882046. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
3
Labs led
1
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 grants

Papers 4

  1. Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. Co-author DOI 10.1136/jitc-2025-012188↗
  2. VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-23-3628↗
  3. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41467-022-34242-4↗
  4. The Potential of CAR T Cell Therapy in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2018.02166↗

Grants 3

  1. Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer R01CA287866↗
  2. Targeting VIP–VPAC Signaling to Reverse Immune Exclusion and Enhance Immunotherapy Response in Pancreatic Cancer R01CA314282↗
  3. Targeting androgen-driven resistance to immune checkpoint inhibitors in pancreatic ductal adenocarcinoma R21CA307819↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gregory B. Lesinski · 3 shared papers, 2 shared grants, 2018–2026 · strength 2.69
  2. Kiranj Kishor Chaudagar · 1 shared paper, 1 shared grant, 2025–2026 · strength 1.80
  3. Chrystal M Paulos · 1 shared grant, 2026 · strength 1.00
  4. Sruthi Ravindranathan · 2 shared papers, 2022–2024 · strength 0.32
  5. Tenzin Passang · 2 shared papers, 2022–2024 · strength 0.32
  6. Bassel F. El‐Rayes · 2 shared papers, 2018–2022 · strength 0.22
  7. Michael B. Ware · 1 shared paper, 2022 · strength 0.12
  8. Mehmet Akce · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.